Oxalic Acid

Oxalic Acid

SCHEMBL5857809

O=C(O)C(=O)O.c1ccc(OCCCCCN2CCCC2)cc1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.88
ALDH1A1 P00352 4/20 0.88
SMN1; SMN2 Q16637 1/20 0.88
HRH3 Q9Y5N1 14/20 0.82
HRH4 Q9H3N8 3/20 0.82
KCNH2 Q12809 2/20 0.82
HRH1 P35367 1/20 0.82
NPC1 O15118 1/20 0.78
HTT P42858 1/20 0.78
RAB9A P51151 1/20 0.78
NPSR1 Q6W5P4 1/20 0.78
L3MBTL1 Q9Y468 1/20 0.78
NPY1R P25929 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL5856239 1.00 KDM4E (0.88) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
Oxalic Acid SCHEMBL5855932 0.98 KDM4E (0.86) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
Oxalic Acid SCHEMBL5856019 0.98 KDM4E (0.91) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
Oxalic Acid SCHEMBL5856230 0.94 KDM4E (1.00) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
Oxalic Acid SCHEMBL27731873 0.92 KDM4E (0.97) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
SCHEMBL491550 0.92 HRH3 (0.79) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
SCHEMBL492176 0.92 HRH3 (0.79) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
SCHEMBL5291543 0.91 HRH3 (0.82) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
SCHEMBL7398556 0.91 HRH3 (0.82) KDM4EALDH1A1SMN1; SMN2HRH3HRH4
SCHEMBL492095 0.91 HRH3 (0.82) KDM4EALDH1A1SMN1; SMN2HRH3HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138413-B1 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders SOCIETE CIVILE BIOPROJET (FR) 2006-11-21 US disclosed